GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (OTCPK:BOIRF) » Definitions » Net Interest Income (for Banks)

BOIRF (Boiron) Net Interest Income (for Banks)


View and export this data going back to 2009. Start your Free Trial

What is Boiron Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Boiron Business Description

Industry
Traded in Other Exchanges
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.